Epoprostenol sodium for treatment of pulmonary arterial hypertension.
Saito Y, Nakamura K, Akagi S, Sarashina T, Ejiri K, Miura A, Ogawa A, Matsubara H, Ito H.
Saito Y, et al. Among authors: ejiri k.
Vasc Health Risk Manag. 2015 May 14;11:265-70. doi: 10.2147/VHRM.S50368. eCollection 2015.
Vasc Health Risk Manag. 2015.
PMID: 25999730
Free PMC article.
Review.